Horiba for Healthcare

03/12/2025

At Hoshi Clinic in Japan, personalized care meets precision. By using simultaneous CBC + CRP measurement, Dr. Hoshi makes fast, accurate decisions—whether to treat on-site or refer to ER.
👉 𝐑𝐞𝐚𝐝 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐢𝐧𝐭𝐞𝐫𝐯𝐢𝐞𝐰: https://bit.ly/4ouWKuK

02/12/2025

Join our upcoming free online workshop: "𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜 𝐀𝐩𝐩𝐫𝐨𝐚𝐜𝐡 𝐟𝐨𝐫 𝐌𝐨𝐧𝐢𝐭𝐨𝐫𝐢𝐧𝐠 #𝐇𝐞𝐩𝐚𝐫𝐢𝐧 𝐓𝐡𝐞𝐫𝐚𝐩𝐲"

📅 Thursday, December 11 | 11:00-12:00 AM CEST
📝 Register: https://horiba.link/1112-25

This session will explore a coordinated, interprofessional approach to safe and effective heparin management, addressing the limitations and variability of current monitoring methods such as aPTT and anti-Xa assays.

𝐖𝐡𝐨 𝐬𝐡𝐨𝐮𝐥𝐝 𝐚𝐭𝐭𝐞𝐧𝐝?
Healthcare professionals and laboratory personnel involved in prescribing, administering, managing, or monitoring patients receiving heparin—particularly those working in critical care, cardiology, hematology, and emergency medicine.

01/12/2025

This World AIDS Day, let’s remember: early and accurate diagnosis is key to managing HIV and saving lives. In-vitro diagnostic solutions support healthcare professionals and patients to detect and monitor HIV effectively.

24/11/2025

🦠💊 𝐏𝐨𝐢𝐧𝐭-𝐨𝐟-𝐜𝐚𝐫𝐞 𝐭𝐞𝐬𝐭𝐢𝐧𝐠 (𝐏𝐎𝐂𝐓) 𝐢𝐬 𝐚 𝐠𝐚𝐦𝐞-𝐜𝐡𝐚𝐧𝐠𝐞𝐫 𝐢𝐧 𝐭𝐡𝐞 𝐟𝐢𝐠𝐡𝐭 𝐚𝐠𝐚𝐢𝐧𝐬𝐭 𝐀𝐌𝐑.
Quick, reliable diagnostics like testing help clinicians distinguish between viral and bacterial infections, ensuring antibiotics are prescribed only when truly needed.

With tools like the delivering results in just 4 minutes, we can take immediate steps to reduce antibiotic misuse and safeguard their future effectiveness.

Discover the Microsemi CRP: https://bit.ly/4a56U1s

21/11/2025

🔬 Chase the Case 50: 𝐀𝐜𝐮𝐭𝐞 𝐋𝐲𝐦𝐩𝐡𝐨𝐛𝐥𝐚𝐬𝐭𝐢𝐜 𝐋𝐞𝐮𝐤𝐞𝐦𝐢𝐚

This month’s clinical case features a 6-year-old patient presented with fever and generalized weakness, diagnosed with Acute Lymphoblastic ( ).

Explore the detailed hematology test results, microscopy findings, and discover how the Yumizen H500 hematology analyzer supported accurate and timely diagnosis.

🌐 View on our website: https://bit.ly/4o8q766
✍ Subscribe: https://bit.ly/3IImlhs

20/11/2025

🦠💊 𝐀𝐧𝐭𝐢𝐛𝐢𝐨𝐭𝐢𝐜 𝐫𝐞𝐬𝐢𝐬𝐭𝐚𝐧𝐜𝐞 𝐢𝐬 𝐫𝐢𝐬𝐢𝐧𝐠—𝐟𝐚𝐬𝐭.
Resistance to last-resort antibiotics could double by 2035 compared to 2005, according to OECD projections. Strong antimicrobial stewardship and better diagnostics are essential to fight this trend.

Diverse organizations provide valuable guidance, recommendations and the interventions necessary to ensure patient care and quality standards. It is with the help of organizations, as well as measures such as rigorous 𝐂-𝐫𝐞𝐚𝐜𝐭𝐢𝐯𝐞 𝐩𝐫𝐨𝐭𝐞𝐢𝐧 ( ) testing (indicating inflammation within the body) that can help to reduce the over and improper use of antimicrobials that lead to the growth in resistance.

As a pioneer, HORIBA offers hematology analyzers that simultaneously measure CRP, delivering comprehensive results. This solution, backed by over 20 years of expertise, supports clinicians in making informed decisions and contributes to global efforts against antimicrobial resistance.

18/11/2025

🦠💊 𝐖𝐨𝐫𝐥𝐝 𝐀𝐧𝐭𝐢𝐦𝐢𝐜𝐫𝐨𝐛𝐢𝐚𝐥 𝐑𝐞𝐬𝐢𝐬𝐭𝐚𝐧𝐜𝐞 𝐀𝐰𝐚𝐫𝐞𝐧𝐞𝐬𝐬 𝐖𝐞𝐞𝐤 𝐢𝐬 𝐡𝐞𝐫𝐞!
Did you know microbes can evolve to resist the very drugs meant to stop them? This growing challenge threatens the effectiveness of and other vital treatments, putting millions at risk worldwide.
Reducing unnecessary antibiotic use and promoting responsible prescribing are key steps to protect these life-saving medicines. Together, we can slow the spread of resistance.

17/11/2025

✅ 𝐐𝐮𝐢𝐳 𝐀𝐧𝐬𝐰𝐞𝐫:
a) Iron status
b) Hemoglobin analysis
The RBC parameters and blood smear are highly suspicious of the patient having Thalassemia; hemoglobin analysis will determine if alpha or beta thalassemia.

Dig deeper into the blood and blood disorders in our hematology newsletter, which focuses on blood morphology bringing you case studies & slide reviews, hemostasis, technologies, clinical advancements, and quizzes: https://www.horiba.com/int/healthcare/heme-insights/heme-insights-5/?utm_source=facebook&utm_medium=share&utm_campaign=hmfr-healthcare-hemeinsights-2025&utm_term=5&utm_content=17112025

It's quiz time with ! A female presents with the following results. The blood smear is Microcytic/Hypochromic, Target Cell, poikilocytosis. Which 2 additional tests should be performed?

a) Iron status
b) Hemoglobin analysis
c) Haptoglobin
d) Liver Function tests
e) Clotting screen

Share your thoughts in the comments and wait for answers next week!

Deep dive into the world of hematology with our newsletter , spotlighting morphology case studies, slide reviews, advances in technology, and exploring blood disorders. 👉 https://bit.ly/4olEnJv

14/11/2025

This year's theme focuses on "Diabetes and the workplace," emphasizing the importance of workplace access to diagnostic tools and care.

With timely and accurate testing, individuals living with diabetes can take control of their wellbeing and live healthier, more empowered lives.

At HORIBA, we are committed to supporting clinics and laboratories through reliable diagnostic solutions that help improve diabetes management.

Monitoring remains a cornerstone measurement in diabetes care. Its ability to reflect the patient's average blood glucose over the prior 2-3 months makes it essential for diagnosis, therapy optimization, and tracking long-term risk. (More about HbA1c: https://bit.ly/4nHBfGy) HORIBA POINTE HbA1c, and reagent portfolio is designed for:
- High accuracy & reproducibility
- Optimized workflow integration
- Streamlined QC + cost-effectiveness

When paired with HORIBA chemistry systems, these reagents help laboratories deliver consistent data that support better clinical decisions-wherever care begins.

Together, we can empower organizations and their teams with the insights they need to build healthier workplaces.

13/11/2025

HORIBA – Pioneer of CBC + CRP analyzers with 20+ years of expertise and trusted innovation in infection diagnostics.​

Driven by the voice of healthcare professionals, HORIBA developed simultaneous CBC + CRP testing—responding to the need for faster, more comprehensive infection screening. From our first analyzer to today’s advanced solutions, we continue to evolve with clinical needs.

12/11/2025

Innovation Meets Collaboration at HORIBA Kyoto💡We were thrilled to welcome Professor Catherine Alix-Panabières from the University of Montpellier for an inspiring day dedicated to Liquid Biopsy: The Journey of a Medical Revolution. From insightful lectures to hands-on workshops and discussions on future projects, this event showcased the power of partnership in advancing oncology research.

Together, we’re shaping the future of cancer diagnostics.